Kathryn Eby Beckermann

8.4k citations
76 papers · 6.3k · 5 hit papers · h-index 31

Impact in

  • Oncology top 1%
    • Cancer Immunotherapy and Biomarkers
    • CAR-T cell therapy research
  • Immunology top 2%
    • Immune Cell Function and Interaction
    • Immunotherapy and Immune Responses
    • Immune cells in cancer

Papers in

Kathryn Eby Beckermann

67 papers receiving 6.2k citations

Kathryn Eby Beckermann's Hit Papers

Obesity induces PD-1 on macrophages to suppress anti-tumour immunity 2024 · 113 citations
1130+2+5Years since publication50010001.5k2.0k

Peers

Kathryn Eby Beckermann
Comparison fields: 5 of 105
  • Oncology 3.1k
  • Immunology 1.4k
  • Cancer Research 707
  • Pulmonary and Respiratory Medicine 1.5k
  • Molecular Biology 1.4k
Replace Sunandana Chandra with:
Sunandana Chandra United States
Wenfeng Fang China
Adam Jacob Schoenfeld United States
Maya Kaushal Leabman United States
Kathryn Cecilia Arbour United States
Boris Sepesi United States
Heidi J. Gray United States
Yingjiang Ye China
Yukio Hosomi Japan
Lizza E.L. Hendriks Netherlands
Kathryn Eby Beckermann relative to Sunandana Chandra United States Sunandana Chandra's profile →
Citations per field
00.5×1.5×1.9×
Sunandana Chandra · 1×
Citations per year

Countries citing papers authored by Kathryn Eby Beckermann

Since Specialization
Citations

This map shows the geographic impact of Kathryn Eby Beckermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kathryn Eby Beckermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kathryn Eby Beckermann more than expected).

Fields of papers citing papers by Kathryn Eby Beckermann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kathryn Eby Beckermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kathryn Eby Beckermann. The network helps show where Kathryn Eby Beckermann may publish in the future.

Co-authors

The 25 scholars most cited alongside Kathryn Eby Beckermann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Kathryn Eby Beckermann Line = papers co-authored together Kathryn Eby Beckermann links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 76 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Fatal Toxic Effects Associated With Immune Checkpoint Inhibitors
Hit paper breakdown →
20182160
2
Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis
Hit paper breakdown →
2018550
3
Kidney Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
Hit paper breakdown →
2022472
4 2017319
5 2021249
6 2018236
7 2019197
8 2018151
9 2020137
10 2020121
11 2017115
12
Obesity induces PD-1 on macrophages to suppress anti-tumour immunity
Hit paper breakdown →
2024113
13 2017111
14 202397
15
NCCN Guidelines® Insights: Kidney Cancer, Version 2.2024
Hit paper breakdown →
202495
16 202077
17 201768
18 201760
19 201854
20 202053

About Kathryn Eby Beckermann

Kathryn Eby Beckermann is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Immunology and Molecular Biology, having authored 76 papers that have together received 6.3k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (31 papers), Cancer Immunotherapy and Biomarkers (25 papers), Cancer, Hypoxia, and Metabolism (10 papers), Cancer Genomics and Diagnostics (8 papers), Immune cells in cancer (7 papers), Renal and related cancers (7 papers), CAR-T cell therapy research (4 papers) and Pancreatic and Hepatic Oncology Research (4 papers). The work is most often cited by research in Oncology (3.1k citations), Immunology (1.4k citations), Cancer Research (707 citations), Pulmonary and Respiratory Medicine (1.5k citations) and Molecular Biology (1.4k citations). Kathryn Eby Beckermann has collaborated with scholars based in United States, France and Italy. Frequent co-authors include Wendy Kimryn Rathmell, Jeffrey C. Rathmell, Benjamin Garrett Vincent, Douglas Buckner Johnson, Stephanie O. Dudzinski, Melissa M. Wolf, Peter J. Siska, Brian I. Rini, Scott Mattox Haake and Anshuman Panda. Their work appears in journals such as The Oncologist, Annals of Oncology, JCI Insight, The Lancet Oncology and Cancers.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact